Lung and XXXX treatment and outcomes in the Veterans Affairs health care system.

@entity5 @entity1 @entity2 @entity14
@entity2 ( @entity2 ) and @entity14 ( @entity14 ) are the second- and third-most commonly diagnosed @entity5 in the Veterans Affairs (VA) health care system. While many studies have evaluated the treatment quality and outcomes of various aspects of VA @entity2 and @entity14 care, there are no known reviews synthesizing this information across studies. The purpose of this literature review was to describe @entity2 and @entity14 treatment (ie, surgical and nonsurgical) and outcomes (eg, mortality, psychosocial, and other) in the VA health care system as reported in the existing peer-reviewed scientific literature. We identified potential articles through a search of published literature using the PubMed electronic database. Our search strategy identified articles containing Medical Subject Headings terms and keywords addressing veterans or veterans' health and @entity2 and/or @entity14 . We limited articles to those published in the previous 11 years (January 1, 2003 through December 31, 2013). A total of 230 articles were retrieved through the search. After applying the selection criteria, we included 74 studies (34 @entity2 , 47 @entity14 , and seven both @entity2 and @entity14 ). VA provides a full array of treatments, often with better outcomes than other health care systems. More work is needed to assess @entity1 -reported outcomes.
